Literature DB >> 23430106

Severe hepatic necrosis of unknown causes following ABO-incompatible liver transplantation.

Hao Lu1, Chuan-Yong Zhang, Wei Ding, Yun-Jie Lu, Guo-Qiang Li, Feng Zhang, Ling Lu.   

Abstract

Emergency ABO-incompatible (ABO-I) liver transplantations (LTx) have been performed increasingly to treat severe liver failure. Herein, we report a case of severe hepatic necrosis after ABO-I LTx. A 53-year-old man with blood group O was diagnosed as having severe hepatitis B and acute-on-chronic liver failure, and underwent an emergency liver transplantation implanting a blood-group-B liver from a cardiac-death donor. A routine anti-rejection, anti-infection and anti-virus therapy was given after operation. On post-operative day (POD) 16, the recipient had fever and erythra. Laboratory and radiographic examinations suggested a severe hepatic necrosis of unknown causes. The patient was managed with a 10-d methylprednisolone pulse therapy. He was discharged on POD 35 with stable condition, and no recurrent disease was found during the follow-up.

Entities:  

Keywords:  ABO-incompatible; Graft rejection; Hepatic necrosis; Liver transplantations; Pulse therapy

Mesh:

Substances:

Year:  2013        PMID: 23430106      PMCID: PMC3574898          DOI: 10.3748/wjg.v19.i6.964

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Trends in immune function assay (ImmuKnow; Cylex™) results in the first year post-transplant and relationship to BK virus infection.

Authors:  Jane Gralla; Janna Huskey; Alexander C Wiseman
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

Review 2.  Humoral immunity and antibody-mediated rejection in solid organ transplantation.

Authors:  Robert A Montgomery; Emanuele Cozzi; Lori J West; Daniel S Warren
Journal:  Semin Immunol       Date:  2011-09-29       Impact factor: 11.130

Review 3.  Liver replacement therapy.

Authors:  Giovanni Tritto; Nathan A Davies; Rajiv Jalan
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

4.  Outcomes following infant listing for cardiac transplantation: the impact of strategies introduced to counteract limited donor availability.

Authors:  C Irving; G Parry; J Cassidy; A Hasan; M Griselli; R Kirk
Journal:  Arch Dis Child       Date:  2010-07-23       Impact factor: 3.791

5.  Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.

Authors:  Y Nakamura; K Hama; H Iwamoto; T Yokoyama; Y Kihara; O Konno; Y Jojima; M Shimazu
Journal:  Transplant Proc       Date:  2012-03       Impact factor: 1.066

Review 6.  Recurrent diseases following liver transplantation: current concepts.

Authors:  Lydia M Petrovic
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

7.  ABO incompatible renal transplantation: a paradigm ready for broad implementation.

Authors:  Robert A Montgomery; Jayme E Locke; Karen E King; Dorry L Segev; Daniel S Warren; Edward S Kraus; Matthew Cooper; Christopher E Simpkins; Andrew L Singer; Zoe A Stewart; J Keith Melancon; Lloyd Ratner; Andrea A Zachary; Mark Haas
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

8.  Multicenter experience of ABO-incompatible pediatric cardiac transplantation.

Authors:  S L Roche; M Burch; J O'Sullivan; J Wallis; G Parry; R Kirk; M Elliot; N Shaw; J Flett; J R L Hamilton; A Hasan
Journal:  Am J Transplant       Date:  2007-11-12       Impact factor: 8.086

9.  Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

Authors:  Tarek I Hassanein; Flemming Tofteng; Robert S Brown; Brendan McGuire; Patrick Lynch; Ravindra Mehta; Fin S Larsen; Jeff Gornbein; Jan Stange; Andres T Blei
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

Authors:  Chuan Li; Kai Mi; Tian fu Wen; Lu nan Yan; Bo Li; Jia ying Yang; Ming qing Xu; Wen tao Wang; Yong gang Wei
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

View more
  2 in total

1.  Intestinal dendritic cells change in number in fulminant hepatic failure.

Authors:  Xu Cao; Mei Liu; Peng Wang; Dong-Yan Liu
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

2.  Problem of living liver donation in the absence of deceased liver transplantation program: Mansoura experience.

Authors:  Mohamed Abdel Wahab; Hosam Hamed; Tarek Salah; Waleed Elsarraf; Mohamed Elshobary; Ahmed Mohamed Sultan; Ahmed Shehta; Omar Fathy; Helmy Ezzat; Amr Yassen; Mohamed Elmorshedi; Mohamed Elsaadany; Usama Shiha
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.